|
Volumn 61, Issue 11, 2001, Pages 1535-1544
|
Should inhaled corticosteroids be used in the long term treatment of chronic obstructive pulmonary disease?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BECLOMETASONE;
BUDESONIDE;
CORTICOSTEROID;
FLUTICASONE PROPIONATE;
TRIAMCINOLONE;
ADULT;
AGED;
ASTHMA;
BONE ATROPHY;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG INDUCED DISEASE;
DRUG MEGADOSE;
FORCED EXPIRATORY VOLUME;
HUMAN;
LUNG EMPHYSEMA;
LUNG FIBROSIS;
MORTALITY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK BENEFIT ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0034815818
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-200161110-00001 Document Type: Review |
Times cited : (17)
|
References (20)
|